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    ABSTRACT  
  
Aim : The aim of the study is to evaluate and compare the presence and distribution 
of α- smooth muscle actin positive stromal myofibroblasts in Normal oral mucosa, 
Potentially Malignant Lesions, Verrucous carcinoma and different histological grades 
of Oral Squamous cell carcinoma. 
Materials and Methods : The study involved 50 formalin fixed paraffin embedded 
tissue samples : 15 cases of normal oral mucosa, 5 cases of OL, OSMF and OLP, 5 
cases of VC, 5 cases of WDSCC,MDSCC and PDSCC each. Expression of 
myofibroblasts using Alpha SMA was analyzed immunohistochemically and the data 
analysis was accomplished using SPSS version 22.0. Chi square test was applied to 
evaluate statistical significance. Intergroup and pair wise comparison group among 
the groups was done by Kruskall-Wallis and Mann Whitney test with p value of ≤0.05 
which was considered as statistically significant. 
Results :  There was no expression in any of the tissues of the normal oral mucosa 
samples which was taken as external negative control. Oral malignant lesions showed 
presence of increased number of myofibroblasts with high staining index when 
compared to oral potentially malignant lesions. Spindle and Network pattern of 
distribution was seen in malignant cases whereas potentially malignant cases showed 
Focal pattern. 
Conclusion : The abundance of myofibroblasts in the stroma of OSCC may be used 
as a stromal marker of aggressive behavior correlating with poor prognosis. It might 
help us in identifying a subset of patients who require more aggressive methods of 
therapy in order to improve their survival rate, and it might also help in early 
intervention and patient counseling for prompt follow‑up. Thus aiding to curb the 
carcinogenesis process and provide an improved quality of life to the patients. 
Keywords:  Potentially malignant, malignant lesions, Myofibroblast, 
Immunohistochemistry, Alpha SMA.
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Oral potentially malignant disorders (OPMDs) have a statistically increased 
risk of cancer progression, but the risk varies according to the range of patient or 
lesion related factors. It is difficult to predict the risk of progression in any individual 
patient and the clinician must make a judgment based on the assessment of each case. 
The most commonly encountered OPMD is leukoplakia, but others, including lichen 
planus, oral submucous fibrosis, and erythroplakia, may also be seen. Factors 
associated with an increased risk of malignant transformation include sex; site and 
type of lesion; habits, such as smoking and alcohol consumption; and the presence of 
epithelial dysplasia on histologic examination.
1
 
Leukoplakia as defined by the World Health Organization (WHO) is a “white 
plaque of questionable risk having excluded (other) known diseases or disorders that 
carry no increased risk for cancer”. The pooled prevalence estimated for leukoplakia 
of the oral cavity is between 1.5% (1.4%–1.6% 95% confidence interval and 2.6% 
(1.7%–2.7% 95% C.I) with no gender predilection.2 The risk factors associated with 
oral leukoplakia and oral cancer are similar which includes tobacco smoking, chronic 
alcohol consumption, betel nut chewing, old age and UV light exposure (for lip 
lesions).
3 
Oral submucous fibrosis (OSMF) is a chronic progressive and irreversible 
disease affecting the oral, oropharyngeal, and rarely the esophageal mucous. OSMF is 
a disease that causes changes similar to those of systemic sclerosis (scleroderma) but 
limited to oral tissues. The disease is prevalent in the Indian subcontinent and many 
parts of South East Asia such as Taiwan. In 1952, Schwartz discovered a disease in 5 
Indian patients which he named as “Atrophia Idiopathica Mucosae Oris.” The same 
disease was described by Pindborg and Sirsat as an insidious, chronic disease 
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affecting any part of the mouth and rarely, the pharynx. It causes significant morbidity 
(in terms of loss of mouth function as the tissues become rigid and mouth opening 
becomes difficult) and mortality (when transformation into OSCC occurs).
4 
Oral lichen planus (OLP) is a chronic inflammatory T cell-mediated disease, 
clinically manifested as white, lacy plaques, located mainly on the buccal mucosa and 
the tongue. Various clinical entities of OLP—namely, reticular, atrophic, plaque-like, 
erosive, and bullous—have been described. Histopathologically, OLP is characterized 
by the presence of a band-like lymphocytic infiltrate at the interface between the 
epithelium and connective tissue and by the destruction of the basal layer 
5 
           Worldwide, oral cancer accounts for 2%–4% of all cancer cases. In some 
regions, the prevalence of oral cancer is higher, reaching approximately 45% in India. 
Oral cancer includes a group of neoplasms affecting any region of the oral cavity, 
pharyngeal regions and salivary glands. However, this term tends to be used 
interchangeably with oral squamous cell carcinoma (OSCC), which represents the 
commonest of all oral neoplasms. It is estimated that more than 90% of all oral 
neoplasms are OSCC.6 Oral Squamous Cell Carcinoma (OSCC) is a major health 
problem world-wide, especially in the developing countries of which Squamous cell 
carcinoma (SCC) is the most common oral cancer in India with an incidence rate as 
high as 30- 40% 
7
 
Oral Verrucous Carcinoma is an uncommon tumor which presents as a tan/ 
white, warty growth with a broad base attachment. The most common sites of 
occurrence include buccal mucosa, mandibular alveolar crest and gingiva. The lesion 
rarely crosses 10 cm in its greatest dimension. Literature depicts that VC most 
commonly occurs in males in the 5-6
th
 decade of life 
8,9 
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Although there is a hypothesis that the presence of myofibroblasts in the 
stroma is entirely dependent on the OSCC development, Cintorino et al. have 
identified MFs are being associated with different grades of cervical intraepithelial 
neoplasia.
10 
Myofibroblasts are large spindle shaped cells defined by indented nuclei, 
stress fibers and well-developed cell-matrix interactions (fibronexus) which are 
contractile in nature.
11 
They are also defined as “Mesenchyme like interstitial cells‟‟, and are 
specialized cells that originate in pathophysiological conditions.
12
 
They are involved in inflammation, wound healing, fibrosis, morphogenesis 
and oncogenesis in many tissues and organs. These cells are found in normal tissues 
and they increase in number during wound healing. They also play a role in formation 
of granulation tissue. Myofibroblasts helps in ECM reorganization by the production 
of numerous inflammatory mediators, growth factors and proteins of the extracellular 
matrix, like collagen, fibronectin, etc. The mediators which are produced by the mast 
cells play a role in the regulation of myofibroblast differentiation and function
. 
The 
myofibroblasts cause contraction of ECM due to their component of α-SMA thereby 
aiding in tissue contraction.
13 
 
Fig : 1 One Cell, Multiple Organs
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Differentiated myofibroblasts are characterized by increased production of 
ECM proteins and by the development of Alpha SMA positive stress fibres which are 
connected to the ECM at the sites of supermature focal adhesion and between the cells 
through adherens junction. 
The microenvironment of stroma of neoplastic tissues play a key role in tumor 
progression. Fibroblasts are considered as one of the most important mesenchymal 
cells involved in tumour progression.  
                   
            Fig 2: The Two-Stage Model of Myofibroblast Differentiation 
A crucial event in tumorigenesis is the transdifferentiation of fibroblasts to 
myofibroblasts which is mediated by growth factors and cytokines expressed by 
tumour cells. The myofibroblasts in turn secrete numerous growth factors and 
inflammatory mediators which stimulates epithelial cell proliferation. Thus 
myofibroblasts have been implicated in the vicinity of invasive oral squamous cell 
carcinoma.
14 
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          Fig 3: Tumor Stromal Interaction in OSCC 
Based on Immunohistochemistry, histopathology and ultrastructure – 
Myofibroblasts can be defined as: 
 Spindle or stellate cell morphology 
 A peri-cellular matrix containing inter alia collagen and glycosamioglycans 
 Palely eosinophilic and prominent cytoplasm. 
Immunophenotype : 
 Vimentin positive  
 Alpha smooth muscle actin positive  
 Non muscle myosin positive  
 Minimal levels of desmin and smooth – muscle myosin 
 EDA cellular fibronectin positive 
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Ultrastructure: 
 Prominent rough endoplasmic reticulum (RER) 
 A golgi apparatus producing collagen secretion granules 
 Modestly developed and frequently peripheral myofilaments with focal 
densities  
 Gap junctions 
 Fibronexuses consisting of converging myofilaments 
 External fibronectin fibril 
 Absence of lamina 
All these definitions applies to the fully differentiated myofibroblast. But in 
granulation tissue or tumour stroma, there are cells evolving into myofibroblasts from 
more primitive precursors however evolving cells lack these features.
15 
 The transdifferentiated MF‟s significantly upregulates the secretion of 
hepatocyte growth factor (HGF/SF), promoting invasion of SCC through the 
basement membrane proteins
16 
A comprehensive recent definition of the myofibroblast(MF) includes light 
microscopy features (spindle or stellate – cell morphology, palely eosinophilic 
cytoplasm and an abundant pericellular matrix), immunophenotype characteristics 
(positivity for markers as alpha smooth muscle actin) and ultrastructure features 
(prominent RER, a golgi apparatus producing collagen secretion granules, peripheral 
myofilament, fibronexus junctions and gap junctions).
17 
Metastasis depends on many interactions among tumour cells and the 
microenvironment, involving a sequence of events characterized by tumor growth and 
angiogenesis, detachment between the tumour cells, invasion of the extracellular 
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matrix (ECM), vascular dissemination, extravasation in target organs and 
establishment of secondary tumour. During the ECM invasion, the tumour cell must 
adhere to its components, promote its degradation by metalloproteinases, and then 
move through the ECM. This dynamic process of ECM remodelling, called 
Stomagenesis orchestrated by stromal myofibroblasts creates a permissive 
environment for tumour growth, invasion and metastasis.
18
 
 The present study was undertaken to compare and evaluate the significance of 
stromal myofibroblasts in OPMD and OMD. 
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AIM: 
The aim of this study is to evaluate and compare the presence and distribution 
of α- smooth muscle actin positive stromal myofibroblasts in Normal oral 
mucosa, Potentially Malignant Lesions, Verrucous carcinoma and different 
histological grades of Oral Squamous cell carcinoma. 
RESEARCH OBJECTIVES: 
 To study stromal myofibroblasts in histopathologically different grades of 
oral squamous cell carcinoma (well differentiated, moderately differentiated, 
poorly differentiated), Verrucous carcinoma, Oral potentially malignant 
disorders (leukoplakia, oral submucous fibrosis and lichen planus). 
 To compare myofibroblast expression among different grades of oral 
squamous cell carcinoma, verrucous carcinoma and oral potentially 
malignant disorders. 
HYPOTHESIS (NULL): 
There is no change in the expression of myofibroblasts among different grades 
of Oral Malignant and Potentially Malignant disorders. 
HYPOTHESIS (ALTERNATE): 
There is a change in the expression of myofibroblasts among different grades 
of Oral Malignant and Potentially Malignant disorders. 
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Sanketh DS et al (2018)
19  
conducted 
 
a study with formalin fixed paraffin embedded 
archival specimens of OLP, OLP with dysplasia, epithelial dysplasia and epithelial 
dysplasia with lichenoid features. They were subjected to immunohistochemical 
staining with α-SMA. Strong staining was noted more frequently in lichenoid 
dysplasia cases [71.4%], followed by OLP cases [42.8%] and OLP with dysplasia 
cases [60%].α-SMA expression do not differentiate between OLP, LP with dysplasia 
and epithelial dysplasia with lichenoid features. 
Akrish et al (2017)
20 
conducted a retrospective clinicopathologic and 
immunohistochemical analysis of 97 tumor specimens from 78 patients (proliferative 
verrucous leukoplakia-associated squamous cell carcinoma (n = 32) and conventional 
squamous cell carcinoma from the buccal mucosa, gingiva, and palate (n = 65). 
Immunostaining with α-SMA antibody was used to evaluate the presence of CAFs .α-
SMA expression was an infrequent finding in p-scca and seen in only 6% of p-scca 
compared to 40% of c-scca (P < 0.0004). The presence of CAFs was not a frequent 
finding in p-scca cohort which may contribute to its slow growing and less invasive 
growth pattern. In the cohort of c-scca patients, higher levels of CAFs correlated with 
microscopic invasiveness, tumor size, and perineural invasion. This study concluded 
that these are the important observations as targeting strategies are being developed 
to combat carcinoma types where CAFs significance has been validated. 
Singh N et al (2017)
21 
assessed 10 cases of OSMF and 10 oral mucosal specimens 
were taken as normal controls from the archives. These cases of OSMF along with 
normal oral mucosa were subjected to immunohistochemistry for α-SMA for 
detection of myofibroblasts. Stromal spindle cells positive for α-SMA were regarded 
as myofibroblasts. Immunostaining was assessed by the evaluation of the staining 
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intensity and percentage of α-SMA-positive cells. None of the OSMF cases showed 
zero staining index while 6 and 4 cases showed moderate and high staining index. 
Thereby concluding that myofibroblasts significantly increases in OSMF patients. 
Ishitha C et al (2017)
22 
subjected 40 sections to IHC using alpha SMA to detect 
myofibroblasts of which 30 were OSMF and 10 were normal. In the present study, 
normal oral mucosa showed complete absence of myofibroblasts. But, on the other 
hand, all the cases of OSMF showed the presence of stromal myofibroblasts, and 
when compared, they were statistically higher in cases of OSMF with dysplasia as 
compared to early and advanced OSMF (p<0.05) suggesting the role of 
myofibroblasts in causing pathological fibrosis in OSMF by the presence of increased 
number of α-SMA positive myofibroblasts, along with change in the distribution 
pattern amongst the cases of early, advanced and OSMF with dysplasia, respectively.  
Gandhi P et al (2017)
23 
evaluated 40 samples of OSCCs, 40 OSMF and 10 samples 
of normal oral epithelium by Alpha-SMA to identify myofibroblasts. The presence of 
myofibroblasts was significantly higher in OSMF compared to normal epithelium and 
in OSCC when compared to OSMF. No significant difference was seen among the 
different grades of OSCC. These findings favour the possibility that OSMF actually 
represents an abnormal healing process in response to irritation caused by areca nut. A 
significant increase in myofibroblasts in OSCC when compared to OSMF highlights 
the important role it may play in the malignant transformation of OSMF. 
Sarode G et al (2017)
24 
conducted a study
 
on
 
30 cases of OSMF and 10 specimens of 
normal buccal mucosa which were subjected to immunohistochemical analysis for 
alpha-smooth muscle actin expression. 100% of NOM and 20% of early OSMF was 
negative, 66.6% of early OSMF and 20% of advanced OSMF showed weak 
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immunostaining and 13.3% of early OSMF and 80% of advanced OSMF showed 
strong immunostaining. Significant differences were observed between normal 
mucosa and OSMF and also among different grades of OSMF.  
Parajuli H et al (2017) 
25 
investigated the presence of myofibroblast using α‐SMA in 
formalin‐fixed paraffin‐embedded (FFPE) samples from 24 healthy volunteers, 32 
oral lichen planus and 106 HNSCC . 100% of OLP cases were negative for alpha 
SMA. In head and neck carcinomas, α‐SMA were detected surrounding the metastatic 
islands. Expression of α‐SMA was found at tumour front but not in the tumour centre 
having a prognostic value for survival, thereby highlighting the importance of 
assessing tumour front when evaluating stromal molecules as prognostic biomarkers. 
Rao et al (2017)
26 
studied 40 cases of OSCC which includes twenty cases each with 
lymph node positive and lymph node negative samples and ten normal oral mucosa  
tissues and subjected them to alpha-smooth muscle actin antibodies. α-SMA 
myofibroblasts were seen in 80% of OSCC and none of the NOM samples showing 
statistical significance. However, their distribution pattern appreciably varied from 
focal pattern to diffuse syncytial pattern. Heterogeneity in the distribution pattern of 
myofibroblasts in tumor stroma indicates that this variability may predict the tumor 
behaviour towards nodal metastasis rather than their mere presence or absence. 
Prasad BV et al (2016)
27 
evaluated 20 specimens of well-differentiated OSCC, 20 
poorly differentiated OSCC and 10 normal healthy controls. All the specimens were 
stained immunohistochemically using monoclonal α-SMA. The mean percentage 
of myofibroblasts score for WDSCC and PDSCC were 2.88 and 2.92 respectively. 
The mean staining intensity score in WDSCC and PDSCC were 2.88 and 2.55 
respectively. Suggesting that malignant epithelium might induce the adjacent 
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stromal tissue to produce myofibroblasts and these specialized cells may be utilized as 
therapeutic targets for the treatment of OSCC. Proliferation of myofibroblasts may be 
used as a stromal marker of premalignancy and malignancy. 
Kanupriya Gupta et al, (2016)
28  
evaluated the presence of stromal myofibroblasts in 
10 samples of normal mucosa ,14 cases of OL, 11 cases of OSMF and 25 cases of 
OSCC by subjecting them to immunohistochemistry using α-SMA. Myofibroblasts 
were not detected in NOM and OL. All OSMF (81.8%- score 2 and 18.2% -score 3) 
and OSCC (16%-score 4 , 28%-score 3, 44%- score 2,12%-score 1) showed positivity 
suggesting the role of MFs with the creation of a permissive environment for tumor 
invasion in OSCC. Thereby concluding the presence of MF as a prognostic marker 
and evaluation of the frequency in the stroma can be used as therapeutic targets.  
Joshi PS et al (2016)
29
 studied twenty cases each of epithelial dysplasia and oral 
squamous cell carcinoma and ten cases of normal mucosa by immunostaining with 
alpha-smooth muscle actin. Blood vessels and normal oral mucosa acted as an internal 
and external control respectively. Of twenty cases of epithelial dysplasia, six (30%) 
were positive, all cases of squamous cell carcinoma and normal mucosa were positive 
and negative for α-SMA expression respectively. No statistical significance was 
observed between the patterns of MF distribution. Statistically significant results of α-
SMA expression were noted in severe grades of dysplasia and between epithelial 
dysplasia and squamous cell carcinoma. Analysis of α-SMA expression for MF 
proliferation can be used as a stromal marker for predicting tumour behavior in oral 
precancer and cancer. 
Dodani et al (2016) 
30  
analyzed 20 cases of OSCC and 20 normal oral mucosa tissues 
by immunohistochemical staining of alpha – SMA for evaluation of myofibroblasts. 
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Significant of mean percentage of myofibroblasts and percentage classification of 
myofibroblasts between OSCCs and NOM suggest increased presence of these cells 
in OSCCs and probably their role in tissue invasion process and progression of 
OSCC. OSCCs had more of spindle pattern of distribution. There is difference in the 
percentage of myofibroblasts between OSCC and NOM (P-value = 0.036˂0.05)  
Jeyaraj et al (2015)
31 
investigated the presence of myofibroblasts in healthy oral 
mucosa (32 cases), potentially malignant disorders (PMDs; (n = 32)) and squamous 
cell carcinoma (SCC; n = 42) by subjecting them to immunohistochemical analysis 
using alpha Smooth Muscle Actin. Among the 42 cases of OSCC, the staining index 
was negative in 54.7%, low in 21.4% and moderate in 23.8%. The stroma of 
Verrucous carcinoma, Hyperkeratosis with epithelial dysplasia, 77.5% of the cases of 
oral Submucous Fibrosis (OSMF) and healthy oral mucosa were devoid of 
myofibroblasts. There was a significant difference in the expression of myofibroblasts 
between the groups. 
Rodrigues et al (2015)
32
 studied the involvement of myofibroblasts in the 
progression of oral squamous cell carcinomas (OSCCs) by determining their density 
in 69 oral potentially malignant disorders (leukoplakias with mild, moderate or severe 
dysplasia), 90 OSCCs (well, moderately and poorly differentiated), 8 oral verrucous 
carcinomas and 29 fibrous hyperplasias by immunohistochemical detection of α 
smooth muscle actin. 100% of leukoplakia,48.6% of WDSCC,23.1% of 
MDSCC,18.8% of PDSCC was Negative, 37.1% of WDSCC,43.6% of MDSCC and 
25% of PDSCC showed Scanty density of MFs and 14.3% of WDSCC,33.3%of 
MDSCC and 56.2% of PDSCC showed Abundant density. The results of this study 
indicated that myofibroblasts are not associated with potentially malignant oral 
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lesions; however, moderately and poorly differentiated OSCCs exhibited a higher 
density of myofibroblasts when compared with well-differentiated tumors. 
Bianco C et al (2015)
33
 evaluated myofibroblast by using IHC in Lip SCC in 12 
well‐differentiated, 8 moderately differentiated and 10 cases of poorly differentiated 
cases using alpha SMA.  Positive α‐SMA cells were counted in the connective tissue 
of 5 equidistant fields per slide, excluding the blood vessels. MFs were observed in 
the connective tissue of all lesions without a statistical difference in the samples 
studied; however, the presence of MFs was higher in malignant disease. 
Bharath Rao et al (2014) 
34
 stated that myofibroblasts are a prominent finding in the 
tumor stroma of many OSCC cases. They evaluated 41 cases of OSMF, 10 cases of 
OSMF with dysplasia and 11 cases of OSCC by subjecting them to 
immunohistochemistry by using (alpha)-SMA antibody to detect myofibroblasts. The 
presence of myofibroblasts was significantly higher in OSCC (100% INTENSE S.I) 
as compared to that in OSMF with dysplasia (100% HIGH S.I)and OSMF (46.3% 
LOW, 39% MODERATE 14.6% ZERO),. Correlation of staining index with the age 
of the individuals and duration of tobacco habit was found to be statistically 
significant 
Paral et al (2014)
35 
analyzed 13 cases of Verrucous hyperplasis, 15 VC, 20 squamous 
cell carcinoma and 16 uninvolved adjacent stroma specimens for α-SMA and CD34 
expression by immunohistochemistry. Stromal α-SMA positivity was observed in 
100% of the SCC and in 93% of the VC, whereas none of the VH or adjacent 
uninvolved stroma demonstrated α-SMA reactivity. The SCC and VC groups differed 
significantly from the VH and uninvolved stroma groups for both α-SMA and CD34 
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expression. Stromal CD34 and α-SMA protein expression patterns may aid in 
distinguishing between VC and VH in challenging cases.  
Majeed AH (2014) 
36
 compared the distribution of myofibroblasts in normal oral 
mucosa, 6 cases of oral epithelial dysplasia, 8 cases of verrucous carcinoma and 10 
cases of different histological grades of OSCC using alpha SMA. 10 cases oral 
squamous cell carcinoma, 50% of oral epithelial dysplasia cases had score 2 (25% of 
MF‟s),  25% of VC had score 1 (less than 25% of MFs), 25% had score 3(25-50% of 
MF‟s).All OSCCs demonstrated stromal immunostaining for α-SMA with Score 
2,3,and 4 indicating the presence of myofibroblast. There were no myofibroblasts in 
the stroma of normal mucosa, epithelial dysplasia or verrucous carcinoma samples 
which is indicated by negative α-SMA expression. This suggests that the genetically 
altered epithelium (carcinomatous epithelium) of OSCC may have an inductive effect 
on the adjacent stroma to produce myofibroblasts. 
Philip T et al (2014)
37
 evaluated 15 cases of OSMF, which were further categorized 
histologically into early (5 cases), moderately advanced (5 cases) and advanced (5 
cases), and 15 benign mucosal proliferation specimens were subjected to 
immunohistochemical evaluation using α-SMA antibody for detection of 
myofibroblasts. 80% of Benign Mucosal Proliferations had Zero and Low S.I whereas 
40% of OSMF cases had LOW, 27% MEDIUM and 7% HIGH S.I. The comparison 
of staining index resulted that number of MFs in OSMF significantly increased to that 
of benign mucosal proliferations (P < 0.05). Thereby the expression of myofibroblasts 
within the OSMF group showed a progressive increase from the early OSMF through 
moderate OSMF and the advanced OSMF group indicating that myofibroblasts could 
serve as effective prognostic marker for disease progression in oral submucous 
fibrosis. 
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Chaudary et al (2012)
38 
compared the presence of myofibroblasts in 37 OSCC, 15 
VC, 15 High Risk Epithelial Dyspalsia (HRED), 15 Low Risk Epithelial Dysplasia 
(LRED) and 15 NOM. Alpha -smooth muscle actin (α-SMA) antibody was used to 
identify myofibroblasts. The α-SMA expression was not observed in NOM and 
LRED. However, it was expressed in 97.29% of OSCC, 86.66% of VC, 46.66 % of 
HRED and found to be significantly higher in OSCC than VC and HRED. It showed 
greater positivity in VC than HRED. Myofibroblastic expression is absent in NOM 
and LRED but increases as the disease progresses from potentially malignant 
disorders, as HRED to VC to invasive OSCC. Thus, proliferation of myofibroblasts 
may be used as a stromal marker of oral premalignancy and malignancy.  
Magda de-Assis et al, (2012)
11 
evaluated the presence of stromal myofibroblasts in 
30 cases of Oral Leukoplakia, 41 cases of OSCC and 10 samples of normal oral 
mucosa by immunohistochemical detection of alpha smooth muscle actin. 
Myofibroblasts were not detected in normal oral mucosa and OL. Stromal 
myofibroblasts were heterogeneously detected in OSCC and it was abundantly present 
in 66.75% of OSCC with a more diffuse histological pattern of invasion. 
Angadi PV et al (2011)
40 
evaluated 70 cases of OSMF immunohistochemically using 
α-SMA to detect myofibroblasts and compared the staining intensity. Fifteen 
normal oral mucosa specimens were taken as controls. The number of α-SMA stained 
myofibroblasts in OSMF was significantly increased when compared to that of the 
normal controls(n=15). 97% of OSMF cases showed moderate and high intensity. 
Additionally, a statistically significant increase in the myofibroblasts population 
between early and advanced stages was observed (P=0.000). The results corroborated 
the possibility that OSMF actually represents an abnormal healing process in response 
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to chronic mechanical and chemical irritation because of areca nut chewing as 
demonstrated by the increased incidence of myofibroblasts in this disease. 
Furthermore, the progressive increase in myofibroblasts from early to advanced stages 
suggests their potential use as markers for evaluating the severity of OSMF. 
Seifi et al (2010)
41 evaluated α-SMA protein frequency in 18 cases of hyperkeratosis, 
18 cases of oral epithelial dysplasia and 18 cases of oral squamous cell carcinoma  
using immunohistochemistry. α-SMA positive expression was observed in 67% of  
OSCC tissue samples with network and spindle patterns, whereas it was seen in 22% 
with a focal pattern in dysplasia and in 6% with a scanty pattern in hyperkeratosis 
cases. These findings suggest that an increase in number of myofibroblasts and 
change in their distribution pattern occurs during carcinogenesis which can be an 
expression of their role in tumor invasive characteristics. 
EtemadMoghadam et al (2009)
15 
subjected 40 oral squamous cell carcinomas, 15 
dysplasias, and 15 sections of normal oral epithelium to alpha-smooth muscle actin to 
evaluate the presence of myofibroblasts and calculate the staining index. The 
percentage and intensity of alpha-smooth muscle actin were examined, and positive 
immunostaining was observed in the myofibroblasts of all squamous cell carcinomas; 
however these cells did not stain in the dysplasias(n=15) or normal epithelium 
specimens(n=15)(Zero S.I). The presence of myofibroblasts was significantly higher 
in oral squamous cell carcinomas (13 High S.I,19 Moderate S.I,8 Low S.I) compared 
to both dysplasias and normal mucosa cases. A significant difference was not 
observed between the different grades of oral squamous cell carcinoma suggesting 
further investigation to clarify the role of myofibroblasts in the carcinogenesis of this 
tumor. 
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Kellermann et al (2007)
41 
studied 83 cases of SCC of the tongue and 34 controls, of 
which 18 were normal oral tissues and 16 premalignant ‘leukoplakias’ with dysplasia. 
Immunohistochemical analyses were performed using a streptavidin- biotin-
peroxidase complex method with the antibodies anti-a-SMA. There were no a-SMA+ 
cells in the stroma of any normal oral mucosal samples or premalignant lesions, 
except in the smooth muscle of the blood vessel walls (internal positive control). In 
contrast, approximately 60% (n = 49) of the SCCs examined contained a significant 
proportion of myofibroblasts. The invasive tumour front was examined in 72 samples, 
revealing that myofibroblasts were concentrated there and demarcated this area in 35 
(71.42%) of the a-SMA+ sample. 
Shi et al (2006)
42 
studied the distribution and expression of alpha-SMA in 60 patients 
with invasive oral squamous cell carcinoma and 20 resections with tumor-free 
margins from 60 patients with invasive oral squamous cell cancer were examined by 
immunohistochemistry Twenty cases of resections with tumor-free margins were free 
of alpha-SMA expression, only the walls of muscularized vessels stained positive 
for alpha-SMA in the stroma. 53 out of 60 invasive oral squamous cell carcinomas 
expressed stromal  myofibroblasts . The detection of alpha-SMA is an adjunctive tool 
in judging oral cancer invasion in small oral mucosa biopsy specimens based on the 
gain of alpha-SMA in the stroma of oral invasive cancer. 
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          Prior to commencement of the study, the research proposal was presented to the 
institutional review board of Best Dental Science College, Madurai, Tamil Nadu and 
ethical clearance was obtained. Appropriate permissions were obtained to collect 
samples from other dental colleges from the same geographical location and also from 
Meenakshi Mission Hospital and Research Centre, Madurai, Tamil Nadu to carry out 
the IHC procedures. 
 
Sample Source: This retrospective study was done by retrieving formalin fixed 
paraffin embedded tissue specimens from the archives of Department of Oral and 
Maxillofacial Pathology, Best Dental Science College and Hospital, Madurai and also 
from other dental colleges of the same geographical location. 
Study sample size: 
The study sample comprised of 50 formalin fixed paraffin embedded tissue specimens 
(archival blocks) which includes 
 20 samples of histopathologically confirmed tissue specimens of Oral 
Malignant lesions.  
 15 samples of histopathologically confirmed tissue specimens of Oral 
Potentially malignant disorders. 
 15 samples of histopathologically confirmed tissue specimens of Normal Oral 
mucosa. 
Study sample group: 
The study comprises of 3 groups: 
Group I (Cases) 
Twenty (n=20) archival blocks of histopathologically confirmed tissue specimens of 
oral Malignant lesions.   
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Group II (Cases) 
Fifteen (n=15) archival blocks of histopathologically confirmed tissue specimens of 
oral potentially malignant disorders. 
Group III (Control) 
Fifteen (n=15) archival blocks of histopathologically confirmed tissue specimens of 
Normal Oral mucosa. 
Inclusion criteria: 
Cases with clinically and histopathologically confirmed diagnosis of 
  Squamous cell carcinoma 
 Well differentiated 
 Moderately differentiated 
 Poorly differentiated   
 Verrucous carcinoma 
 Leukoplakia 
 Lichen planus  
 Oral submucous fibrosis 
 Normal Oral mucosa is retrieved from patients undergoing impacted molar 
tooth removal and other periodontal procedures. 
Exclusion criteria: 
 Secondary and metastatic tumors of oral squamous cell carcinoma were 
excluded. 
 For normal mucosa, biopsies of the subjects with signs of inflammatory 
gingival and periodontal diseases were excluded. 
 Insufficient tissue samples. 
 Recurrent cases. 
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Method: 
From the clinically and histopathologically confirmed formalin fixed paraffin 
embedded blocks, sections of 4 micron thickness was cut and stained with routine 
hematoxylin and eosin (H and E) staining. Cases that met the histological criteria of 
well differentiated, moderately differentiated, poorly differentiated oral squamous cell 
carcinoma, oral leukoplakia, oral lichen planus, oral submucous fibrosis were selected 
for the immunohistochemical analysis. Later these selected slides were subjected to 
IHC procedures which was carried out at Meenakshi Mission Hospital and Research 
Centre, Madurai, Tamil Nadu. 
IMMUNOHISTOCHEMISTRY PROCEDURE: 
EQUIPMENTS REQUIRED: 
 Magnetic stirrer (Fig 4) 
 Electronic weighing machine (Fig 5) 
 Potential of Hydrogen (pH) meter (Fig 6) 
 Slide Warmer  
 Fine tissue paper. 
 Slide rack. 
 Borosil jars. 
 Measuring cylinder 
 Fully automated microtome (Leica RM2125RT) (Fig 7) 
 Slide truft. 
 APES coated slides. 
 Moist chamber. 
 Forceps. 
 Micropipettes (10-100/5-10 microliter)  
 Refrigerator. 
 Light microscope (Olympus BX53®) Fig 9 
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                            Fig 4 : Magnetic Stirrer with Hot Plate 
                                         
                                         Fig 5: Weighing Machine  
                              
                                                    Fig 6: Ph Meter  
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                                   Fig: 7 Fully automated Microtome 
                               
                       Fig 8: Automatic IHC Stainer (BioGenex  i6000) 
                              
                      Fig 9: Light microscope Olympus BX53 using ProgRes  
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CHEMICAL REAGENTS USED: 
 XYLENE 
 ISOPROPYL ALCOHOL 
 TRI SODIUM CITRATE 
 SODIUM CHLORIDE 
 TRIS BUFFER 
 SODIUM HYDROXIDE 
 HYDROCHLORIC ACID 
 DISTILLED WATER 
 HYDROGEN PEROXIDE 
 METHANOL 
 HEMATOXYLIN 
 AMINO PROPYL ETHOXY SILANE (3‟ AMINO PROPYL ETHANOL) 
 
  
Fig 10: tri – Sodium Citrate Fig 11: Chemicals for preparation of Tris 
Buffer Saline (TBS) 
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Fig 12: Primary Antibody  
                               
               Fig 13: Secondary Antibody 
 
 
                             
                                     
 
 
Fig 14: Tertiary Antibody 
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          Fig 15 :  DAB Buffer 
                                  
    Fig 16 : Liquid DAB Chromogen 
STAINING PROCEDURE: 
 The sections were taken in  2% APES coated slides 
 Label the section with pencil appropriately 
 Placed in Slide warmer at 60-65 degree centigrade temperature for 30 minutes 
 Place in Hot air Oven for 30 minutes 
 Transfer it directly to xylene – 3 changes -10 minutes each 
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 Two changes of absolute alcohol - 2 changes – 10 minutes each 
 Rinse gently in running water for 5 minutes each  
 Rinse in distilled water 
 Place the slides in the 0.01M citrate buffer pH 6.0 pressure cooker heating 
(Pressure cooker with an operating pressure of about 103kpa/115 will ensure 
the temperature of about 160 degree centigrade at full pressure) 
 After boiling, it is cooled by transferring it to a sink with cold running water or 
the slides are removed from the pressure cooker quickly washed in running 
distilled water, transfer to TBS for 10 minutes. 
 Block endogenous peroxidase by 3% hydrogen peroxidase for 10 minutes 
 Rinse in TBS then power block for 10 minutes 
 The slides are then incubated with primary antibody for 1 hour for nuclear and 
half an hour for membranous and cytoplasmic antibody staining. 
 Rinse in TBS 
 Slides are then incubated with Super enhancer for 20 minutes 
 Rinse in TBS 
 Slides are then incubated with HRP - Polymer for 30 minutes 
 Rinse in TBS  
 Excess of buffer is wiped and then slides are incubated with substrate / 
chromogen for 7 minutes. Rinse in TBS 
 Rinse in distilled water 
 Stain with hematoxylin for 1 minutes 
 Dehydrate and Mount 
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EVALUATION METHOD: 
The IHC slides were viewed using an Olympus
®
 BX53 light microscope and 
compared with their respective H&E sections. Photomicrographs of the IHC stained 
slides were done using ProgRes Speed XT Core 3
®
. To minimize the errors while 
interpretation, examination of the IHC stained slides was done by two observers using 
a light microscope. All the immunohistochemically stained slides from the study 
groups I, II and III were evaluated for the expression of Alpha Smooth muscle actin 
immunopositivity was assessed by the presence of a brown colour immunostaining. 
Stromal Spindle cells which showed positivity for 𝛼– SMA were considered as 
Myofibroblasts.
 
EVALUATION CRITERIAS : 
The Staining intensity was estimated based on the criteria followed by Gupta et al: 
 0%- No staining 
 1% -In parts where positivity was observed only at a magnification of 
x400 
 
 2%- In cases where the staining was obvious at x100, but not at x40 
 3%- In fields where immunopositive cells were seen even at x40.  
The percentage of 𝜶 - SMA immunopositivity was categorized based on the 
criteria adopted by Gupta et al 
The percentage of 𝛼 - SMA immunopositive cells was estimated and graded, in  
 0 %: No immunopositive cells 
 1%: 1-25% immunopositive cells 
 2%: 25% to 50% immunopositive cells 
 3% : 50% to 100% immunopositive cells 
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Evaluation of 𝜶 - SMA 
The immunoreactivity of 𝜶 - SMA in all the groups was assessed by calculating the 
Staining Index according to the method proposed by Etemad Moghadam et al: 
S.I = Percentage of immunopositive cells x Intensity of immunostaining  
The S.I score was translated into 𝜶 - SMA immunoreactivity as follows 
 Zero (0) 
 Low (1,2) 
 Moderate (3,4) 
 High (6-9) 
Evaluation of the pattern of distribution of 𝜶 - SMA Immunoexpression based 
on the criteria proposed by Vered M et al: 
The pattern 𝜶 - SMA expression in all the groups was recorded based on their 
localization as 
 FOCAL 
 SPINDLE  
 NETWORK 
STATISTICAL ANALYSIS : 
All relevant clinical, histopathological and immunohistochemical data were entered in 
Microsoft Excel. Data Analysis was done with the help of computer and subjected to 
appropriate statistical analysis using. Statistical Package for Social Sciences (SPSS 
Inc.,Chicago, IL, Version 22.0 for Windows). 
Using this software, frequencies and percentages were calculated for qualitative 
variables. Chi square and „p‟ values were also calculated. Kruskal Wallis Test and 
Mann Whitney tests were done for intergroup and pair wise comparison. 
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CLINICAL CHARACTERISTICS OF THE STUDY SAMPLE 
The study group comprised of 50 cases which includes 15 samples of OPD, 20 
samples of OM and 15 samples of NOM. The mean age of the patients included in the 
study was 49.6 years and ranged from 31 to 70 years. Majority of these cases were 
from buccal mucosa (n=25, 50%). Other samples were derived from gingiva (n=15, 
30%), lip (n=6, 12%) alveolus (n=3, 6%) tongue (n=1, 2%). The clinical 
characteristics of the pathological conditions included in the analysis are presented in 
Table 1. 
The samples of OPD were obtained from 10 males (66.7%) and 5 females (33.3%). 
The patient‟s mean age was 54.2 years and ranged from 37 to 70 years. Majority of 
these cases were from buccal mucosa (n=12, 80%). Other sites reported were lip (n=2. 
13.3%) and alveolus (n=1, 6.7%). 
Of the 20 OM, 12 samples (60%) were from males and 8 (40%) from females. The 
mean age of these patients was 53.6 years ranging from 31 to 67 years. The samples 
were obtained from buccal mucosa (n=13, 65%), lip (n=4, 20%), alveolus (n=2, 10%) 
and tongue (n=1, 5%) 
The NOM control group includes 7 (46.7%) females and 8 (53.3%) males with a 
mean age of 39.5 years ranging from 31 to 49 years. All samples (100%) were 
obtained from the gingiva. 
In the OL sub category, 3 (60%) males and 2 (40%) females with a mean age of 52.6 
years ranging from 37 to 70 years were selected. All 5 (100%) samples were obtained 
from buccal mucosa. 
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In the OSMF sub category, all samples were from males 5 (100%) with a mean age of 
52.6 years ranging from 37 to 70 years were selected. All 5 (100%) samples were 
obtained from buccal mucosa. 
In the OLP subcategory, 3(60%) were from females and 2(40%) were from males 
with a mean age 54.8 with a age range of 40 – 66 years. 2(40%) samples were from 
buccal mucosa, 2(40%) samples were from lip and 1 (20%) sample from alveolus. 
In the VC subcategory 3(60%) were from males and 2(40%) were from females with 
a mean age of 55 ranging from 48-58 years. 3(60%) were obtained from buccal 
mucosa , 2(40%) were taken from the lip. 
In the WDSCC subcategory, the samples were obtained from a majority 4(80%) of 
males, 1(20%) was from a female with a mean age of 47.8 ranging from 31-62 years. 
4(80%) were obtained from buccal mucosa and 1 (20%) sample was from lip. 
In the MDSCC subcategory 4(80%) were from females and 1(20%) was from female 
with a mean age of 59.8 ranging from 54 -67 years. 2(40%) samples were taken from 
alveolus, 1(20%) from tongue, 1(20%) from lip, 1(20%) from buccal mucosa. 
In the PDSCC subcategory 4(80%) were from males, 1(20% was from female with a 
mean age of 52 ranging from 36 to 67. All the samples were taken from buccal 
mucosa    (n=5 100%). 
In the NOM control group 8(53.3%) samples were from males and 7(46.7%) from 
females with a mean age of 39.5 years ranging from 31 to 49 years. All the samples 
(n= 15, 100% ) were obtained from gingiva. 
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Comparison of PERCENTAGE of -SMA positive myofibroblasts in the 
connective tissue of the study groups: 
The myofibroblasts in the connective tissue stained positive for Alpha SMA.  
Table 2 and Graph 1 compares the percentage of  SMA positive myofibroblasts in 
the connective tissue of the study groups. 1%(1-25%) of immunopositivity was 
observed in 7 (46.6%) cases of OPMD Group, and 2 (13.32%) cases showed 2%    
(25-50%) and the remaining 6 (40%)cases were negative for  SMA. 
The percentage of immunopositive cells was less in oral potentially malignant group    
Among the sub category of OPD, 3(60%) cases of OL and OMFS showed 
0%(negative staining), 1%(1-25%) of immunopositivity was observed in 2(40%) 
cases of OL ,OMFS and 3(60%) cases of OLP .2%(25-50%) was observed in 2(40%) 
cases of OLP. 
Graph 4 demonstrates the percentage of cells. In the malignant category , 8(40%) had 
1%(1-25%) of immunopositivity, 8(40%) had 2%(25-50%) of immunopositivity and 
4(20%) had 3%(50-100%) of immunopositive cells. 
Among the subcategory of OMD, All 5(100%) and 3(60%) cases of VC and WDSCC 
respectively showed 1% (1-25%) immunopositivity, 2(40%) WDSCC, 4(80%) 
MDSCC and 2(40%) PDSCC cases showed 2%(25-50%) of immunopositivity. 
As the grade of malignancy increases the percentage of alpha SMA immunopositive 
cells increases i.e 3% of immunopositivity was observed in malignant lesion showing 
statistical significance. 
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On Comparison within the OPMD and OMD group, the percentage of alpha SMA 
immunopositive cells was found to be statistically significant with a p value of 0.039 
and 0.006 respectively. 
All 15(100%) cases of NOM were negative for alpha SMA. Statistical significance 
was observed among the groups. 
Comparison of INTENSITY of -SMA positive myofibroblasts in the connective 
tissue of the study groups: 
The intensity of staining of alpha SMA positive stromal myofibroblasts was compared 
among the three study groups in Table 3 and Graph 2. In the OPMD group, 
7(46.2%) showed 1% intensity, (13.2%) cases showed 2% intensity whereas (39.6%) 
of cases were negative. 
Majority of the cases (60%) of both OL and OSMF subcategory were negative. 
Remaining (40%) of both OL and OSMF showed positivity under 400X whereas 
3(60%) cases of oral lichen planus showed positivity under 400X and 2(40%) showed 
positivity under 100X but not under 40X. 
Graph 6 shows the staining intensity in the malignant category, majority of cases 
8(40%) showed 2% intensity, 6(30%) showed 3% intensity and the remaining 6(30%) 
was positive under 400X. 
In the OMD sub category  all 5(100%)cases of VC ,and only 1(20%)case of WDSCC 
showed were positive under 400X showing 1% of staining intensity .Of the remaining 
3 sub categories 2(40%) out of 5 cases showed 3% staining intensity which was 
positive even under 40X .2% intensity was seen in 2(40%) of WDSCC,3(60%) of 
MDSCC and 3(60%) of PDSCC which was positive under 100X but not under 40X. 
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On comparison within the OPMD and OMD groups, the staining intensity of Alpha 
SMA immunopositive cells was not significant as the p value was found to be 0.307 
and 0.579 respectively. 
All 15(100%) cases in the NOM control group revealed negative staining intensity. 
Comparison of STAINING INDEX of -SMA positive myofibroblasts in the 
connective tissue of the study groups: 
Table 4 and Graph 3 compares the staining index of alpha SMA positive stromal 
myofibroblasts among the three study groups. 
In the OPMD group, the staining index was Zero in 6(39.96%) cases, Low in 
7(46.2%) cases and Moderate in 2(13.32%) cases. 
In OPMD subcategory, the staining index was ZERO in 3(60%) cases out of 5 in both 
OL and OSMF, it was Low in 2(40%) cases out of 5 in both OL ,OSMF and 3(60%) 
cases of OLP. The remaining 2(40%) cases of OLP had Moderate staining index. 
Graph 7 explains the staining index of alpha SMA positive stromal myofibroblasts. 
In the OMD group, the staining index was Moderate in a majority of 8(40%) cases 
whereas an equal distribution of Low and High staining index was observed in 
6(30%) cases respectively. 
In the OMD sub category, in all the cases of Verrucous Carcinoma the staining index 
was low and in 1(20%) case of WDSCC, Moderate  staining index was noted in 
2(40%) cases of WDSCC, 3(60%) MDSCC and 3(60%) PDSCC cases and high in 
2(40%) cases of both moderately and poorly differentiated squamous cell carcinoma. 
All 15(100%) cases in the NOM control group had Zero staining index. 
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The staining index was predominantly zero and low in potentially malignant disorders 
whereas it was moderate and high in case of malignant disorders. 
On comparison within the OPMD and OMD groups the staining index of alpha SMA 
positive stromal myofibroblasts was found to be statistically significant with a p value 
of 0.039 and 0.011 respectively. 
Comparison of DISTRIBUTION PATTERN of -SMA positive myofibroblasts 
in the connective tissue of the study groups: 
In the connective tissue the distribution of alpha SMA positive Myofibroblasts was 
seen in different patterns. Table 5 and Graph 4 compares the distribution pattern of 
alpha SMA positive stromal myofibroblasts among the three study groups. In the 
OPMD group, Majority 7(46.62%) cases showed focal pattern, 1(6.66%) cases 
showed spindle pattern, 1(6.66%) showed network pattern and the remaining  
6(39.96% ) were negative. 
Focal pattern of distribution was seen in oral potentially malignant disorders whereas 
oral malignant disorders showed a predominant Network pattern. 
Among the subcategories of OPMD, 3(60%) cases of OL and OSMF each did not 
express alpha SMA. 1(20%) exhibited focal pattern and 1(20%) exhibited spindle 
pattern in OL. 2(40%) OSMF and 4 (80%) OLP cases exhibited focal pattern and 
1(20%) case of OLP exhibited Network pattern showing more potential for malignant 
transformation. 
On comparison within the OPMD and OMD groups, the distribution pattern among 
the oral potentially malignant group and potentially malignant group was not 
significant as the p value was found to be 0.127 and 0.105 respectively. 
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Graph 8 compares the pattern of distribution Among the OMD group, Spindle pattern 
of distribution was predominant in 11(55%), 5(25%) showed network pattern, Only 
1(5%) exhibited focal pattern and 3(15%) cases showed no expression. 
3(60%) cases of Verrucous Carcinoma did not express alpha SMA. Only 1(20%) case 
of WDSCC exhibited focal pattern, Spindle pattern was observed in 2(40%) cases of 
VC, 4(80%) cases of WDSCC, 2(40%)cases of MDSCC and 3(60%)PDSCC cases. 
Network pattern was mainly exhibited by the different grades of squamous cell 
carcinoma 1(20%) WDSCC, 2(40%) MDSCC and 2(40%) PDSCC Cases. 
All the 15(100%) cases of NOM were negative for alpha SMA. 
Summary of intergroup analysis of the study samples: 
The Percentage, Intensity, staining index and Pattern of distribution of Alpha SMA 
positive myofibroblasts among the study groups were analyzed statistically using 
Kruskal Wallis Test. Based on the statistical analysis, very high significance for alpha 
SMA expression was seen among the 3 groups in all four parameters. (P=0.000). The 
intergroup comparison and outcome of the analysis between the study groups is 
summarized in Table 6. 
The percentage, intensity, staining index and distribution was higher in oral 
potentially malignant disorders when compared to malignant disorders with a high 
statistical significance of (p =0.000) 
Similarly on comparison of Oral malignant disorders with that of normal oral mucosa 
and comparison of oral potentially malignant with that of Normal oral mucosa, very 
high statistical significance was noted with a p value of 0.000. 
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Comparison within the oral malignant disorders using Chi square test showed 
statistical significance in percentage and staining index with a p value of 0.004 and 
0.010 respectively but there was no statistical significance in the staining intensity and 
pattern of distribution as the p value was 0.374 and 0.163 respectively  
On Pairwise Comparison using Mann Whitney test, statistical significance for Alpha 
SMA expression was noted only between OSMF and OLP in the percentage 
(p=0.031), staining index (p=0.031) and distribution(p=0.042) (Table 7). On 
comparing OL and OLP, the percentage, intensity, statistical significance was 
observed in the percentage and staining index with the p value of 0.031. The rest of 
the pair wise comparison was not significant (Table 7) 
Key: "p" is level of significance, (p> 0.05 - Not significant; p <0.05 – Significant;       
p <0.01 - Highly significant; p <0.001 - Very highly significant). 
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TABLE 1  
Clinical characteristics of each pathological condition included in the analysis 
 
Category Normal 
Oral 
Mucosa 
Oral  Potentially Malignant  Oral  Malignant  
OL OSMF OLP VC WDSCC MDSCC PDSCC 
Sex Male 8 (53.3%) 3(60%) 5(100%) 2(40%) 3(60%) 4(80%) 1(40%) 4(80%) 
Female 7(46.7%) 2(40%) 0 3(60%) 2(40%) 1(20%) 4(60%) 1(20%) 
Age 30-40 8(53.3%) 2(40%) 0 1(20%) 0 1(20%) 0 1(20%) 
41-50 7(46.7%) 0(0%) 2(40%) 1(20%) 1(20%) 2(40%)       0 2(40%) 
51-60 0 1(20%) 1(20%) 1(20%) 4(80%) 1(20%) 3(60%) 0 
61-70 0 3(60%) 2(40%) 2(40%) 0 1(20%) 2(40%) 2(40%) 
Site Buccal 
mucosa 
0 5(100%) 5(100%) 2(40%) 3(60%) 4(80%) 1(20%) 5(100%) 
Lip 0 0 0 2(40%) 2(40%) 1(20%) 1(20%) 0 
Alveolus 0 0 0 1(20%) 0 0 2(40%) 0 
Tongue 0 0 0 0     0 0 1(20%) 0 
Gingiva 15(100%) 0 0 0 0 0 0 0 
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      TABLE 2 
Comparison of PERCENTAGE of  - SMA positive myofibroblasts in the 
connective tissue of the study groups  
 
*P≤0.05 Statistically significant 
 
 
  
N 
0% 
(No cells) 
1% 
(1-25%) 
2% 
(25-50%) 
3% 
(50 -100%) 
P Value 
OL 5 3(60%) 2(40%) 0 0  
 
 
 
0.039* 
OSMF 5 3 (60%) 2(40%) 0 0 
OLP 5 0 3(60%) 2(40%) 0 
OPMD 15 6(40%) 7(46.6%) 2(13.32%) 0 
VC 5 0 5(100%) 0 0  
 
 
 
 
0.006* 
WDSCC 5 0 3(60%) 2(40%) 0 
MDSCC 5 0 0 4(80%) 
 
1(20%) 
PDSCC 5 0 0 2(40%) 3(60%) 
OMD 20 0 8(40%) 8(40%) 4(20%) 
NOM 15 15(100%) 0 0 0  
Total 50 21(42%) 15(30%) 10(20%) 4(8%)  
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TABLE 3 
Comparison of -SMA STAINING INTENSITY in the connective tissue of study 
group 
 
*P≤0.05 Statistically significant 
 
  
N 
       0% 
(Negative) 
1% 
(Mild) 
2% 
(Moderate) 
3% 
(Severe) 
P Value 
OL 5 3(60%) 2(40%) 0 0  
 
 
 
0.307 
 
 
OSMF 5 3(60%) 2 (40%) 0 0 
OLP 5 0 3(60%) 2(40%) 0 
OPMD 15 6(39.6%) 7(46.2%) 2(13.2%) 0 
VC 5 0 5(100%) 0 0  
 
 
 
0.579 
WDSCC 5 0 1(20%) 2(40%) 2(40%) 
MDSCC 5 0 0 3(60%) 2(40%) 
PDSCC 5 0 0 3(60%) 2(40%) 
OMD 20 0 6(30%) 8(40%) 6(30%) 
NO 15 15(100%) 0 0 0  
Total 50 21(42%) 13(26%) 10(20%) 6(12%)  
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TABLE 4 
Comparison of -SMA STAINING INDEX in the connective tissue of study 
group 
 
 N ZERO LOW MODERATE HIGH P Value 
OL 5 3(60%) 2(40%) 0 0  
 
 
 
0.039* 
OSMF 5 3(60%) 2(40%) 0 0 
OLP 5 0 3(60%) 2(40%) 0 
OPMD 15 6(39.96%) 7(46.62%) 2(13.32%) 0 
VC 5 0 5(100%) 0 0  
 
 
 
 
0.011* 
WDSCC 5 0 1(20%) 2(40%) 2(60%) 
MDSCC 5 0 0 3(60%) 2(40%) 
PDSCC 5 0 0 3(60%) 2(40%) 
OMD 20 0 6(30%) 8(40%) 6(30%) 
NOM 15 15(100%) 0 0 
 
0 
 
 
Total 50 21 
(42%) 
13 
(26%) 
10 
(20%) 
6 
(12%) 
 
 
*P≤0.05 Statistically significant 
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TABLE 5 
Comparison of -SMA distribution Pattern in the connective tissue of study 
group 
 
 N No 
expression 
FOCAL SPINDLE NETWORK P 
Value 
OL 5 3(60%) 1(20%) 1(20%) 0  
 
 
0.127 
OSMF 5 3(60%) 2(40%) 0 0 
OLP 5 0 4(80%) 0 1(20%) 
OPMD 15 6(39.96%) 7(46.62%) 1(6.66%) 1(6.66%)  
VC 5 3(60%) 0 2(40%) 0  
 
 
 
0.105 
WDSCC 5 0 0 4(80%) 1(20%) 
MDSCC 5 0 1(20%) 2(40%) 2(40%) 
PDSCC 5 0 0 3(60%) 2(40%) 
OMD 20 3(15%) 1(5%) 11(55%) 5(25%)  
NO 15 15(0%) 0 0 0  
Total 50 24(48%) 8(16%) 12 (24%) 6(12%)  
 
P≤0.05 Statistically significant 
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TABLE 6 
Intergroup Comparison of α-SMA Immunopositivity in the Connective Tissue Of 
Study Groups By Chi Square Test: 
 
 
 
 
 
 
 
 
 
 
TABLE 7 
Pairwise comparison among the study groups in connective tissue for alpha SMA 
staining by Mann Whitney Test: 
*P≤0.05 Statistically significant 
Parameters Study group Cases P-Value 
Percentage OPMD 15 χ
2
=35.30 
.000* OMD 20 
NOM 15 
Intensity OPMD 15 χ
2
=35.79 
.000* OMD 20 
NOM 15 
Staining Index OPMD 15 χ
2
=35.48 
.000 * OMD 20 
NOM 15 
Distribution OPMD 15 χ
2
=34.62 
.000* OMD 20 
NOM 15 
 
Study Group 
Connective Tissue 
P-Value 
Percentage Intensity Staining Index Distribution 
 
 
 
OPMD 
 
OL .902 .811 .911 .811 
OSMF 
OSMF .031 .121 .031 .042 
OLP 
OL .031 .319 .031 .142 
OLP 
 
 
 
 
OMD 
VC .676 .403 .676 .543 
WDSCC 
WDSCC .221 .220 .221 .221 
MDSCC 
MDSCC .327 .636 .327 .112 
PDSCC 
VC .650 .549 .650 .309 
PDSCC 
VC .606 .636 .606 .890 
MDSCC 
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GRAPH 1 
Comparison of PERCENTAGE of -SMA positive myofibroblasts in study 
groups  
 
 
 
GRAPH 2 
Comparison of -SMA STAINING INTENSITY in the connective tissue of study 
group 
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GRAPH 3 
Comparison of -SMA STAINING INDEX in the connective tissue of study 
group 
 
 
 
GRAPH 4 
Comparison of -SMA distribution pattern in the connective tissue of study 
group 
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GRAPH 5 
Percentage of Immunopositive Myofibroblasts In Oral Malignant Lesions 
 
 
      
GRAPH  6 
Staining Intensity Of Myofibroblasts In Oral Malignant Lesions 
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GRAPH 7 
Staining Index Of Myofibroblasts In Oral Malignant Lesions 
 
 
 
GRAPH 8 
Distribution Pattern Of Myofibroblasts In Oral Malignant Lesions 
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ORAL LEUKOPLAKIA 
 
FIG 17A ORAL LEUKOPLAKIA SHOWING 
DYSPLASTIC CHANGES IN EPITHELIUM AND 
UNDERLYING CONNECTIVE TISSUE 
(H & E 100X) 
 
 
        FIG 17B SHOWING  ALPHA SMA MILD     
INTENSITY OF IMMUNOPOSITIVITY (100X) 
 
FIG 17C SHOWING DYSPLASTIC CHANGES IN 
EPITHELIUM AND UNDERLYING CONNECTIVE TISSUE 
(H & E 200X) 
 
     FIG 17D SHOWING  ALPHA SMA FOCAL PATTERN 
OF DISTRIBUTION OF MYOFIBROBLASTS IN THE 
CONNECTIVE TISSUE ( 200X) 
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ORAL SUBMUCOUS FIBROSIS 
 
 
FIG 18A ORAL SUBMUCOUS FIBROSIS  SHOWING 
SURFACE EPITHELIUM AND UNDERLYING  FIBROUS 
COLLAGEN BUNDLES IN THE CONNECTIVE TISSUE     
(H & E 100X) 
 
 
 
FIG 18B ORAL SUBMUCOUS FIBROSIS  NEGATIVE  
FOR ALPHA SMA EXCEPT BLOOD VESSELS (100X) 
 
 
FIG 18C ORAL SUBMUCOUS FIBROSIS SHOWING 
SURFACE EPITHELIUM AND UNDERLYINGFIBROUS 
COLLAGEN BUNDLES IN THE CONNECTIVE TISSUE  
(H & E 200X) 
 
 
FIG 18D SHOWING MILD ALPHA SMA IN THE 
CONNECTIVE TISSUE ( 200X) 
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ORAL LICHEN PLANUS 
 
 
FIG 19A ORAL LICHEN PLANUS SHOWING SURFACE 
EPITHELIUM WITH BASAL CELL DEGENERATION AND 
LYMPHOCYTIC INFILTRATION IN THE CONNECTIVE 
TISSUE (H & E 100X) 
 
 
 
 
FIG 19B SHOWING SEVERE ALPHA SMA STAINING IN 
THE CONNECTIVE TISSUE (100X) 
 
 
FIG 19C ORAL LICHEN PLANUS SHOWING BASAL CELL 
DEGENERATION AND LYMPHOCYTIC INFILTRATION IN 
THE CONNECTIVE TISSUE  
(H & E 200X) 
 
 
FIG 19D  SHOWING NETWORK PATTERN OF 
DISTRIBUTION OF  ALPHA SMA POSITIVE 
MYOFIBROBLASTS IN THE CONNECTIVE TISSUE  
 ( 200X) 
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VERRUCOUS CARCINOMA 
 
 
FIG 20A SHOWS VERRUCOUS CARCINOMA 
PROLIFERATIVEEPITHELIUM AND UNDERLYING 
CONNECTIVE TISSUE (H & E 100X) 
 
 
 
 
FIG 20B  SHOWING MILD  ALPHA SMA IN THE 
CONNECTIVE TISSUE ( 100X) 
 
 
FIG 20C SHOWING  VERRUCOUS CARCINOMA  IN 
EPITHELIUM AND UNDERLYING CONNECTIVE TISSUE   
(H & E 200X) 
 
FIG 20D  SHOWING FOCAL PATTERN OF 
DISTRIBUTION OF ALPHA SMA POSITIVE 
MYOFIBROBLASTS IN THE CONNECTIVE TISSUE  
( 200X) 
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WELL-DIFFERENTIATED SQUAMOUS CELL CARCINOMA 
 
FIG 21A SHOWING INFILTRATION OF ISLANDS OF 
MALIGNANT EPITHELIAL CELLS INTO THE UNDERLYING 
CONNECTIVE TISSUE (H & E 100X) 
 
 
 
FIG 21B  SHOWING MODERATE STAINING   
ALPHA SMA STAINING IN THE CONNECTIVE  
TISSUE ( 100X) 
 
 
 
FIG 21C  SHOWING MODERATE  ALPHA  
SMA STAINING IN THE CONNECTIVE  
TISSUE ( 100X) 
 
 
 
 
 
FIG 21D  SHOWING MODERATE ALPHA  
SMA STAINING IN THE CONNECTIVE  
TISSUE ( 100X) 
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       MODERATELY DIFFERENTIATED SQUAMOUS CELL CARCINOMA 
 
 
FIG 22A SHOWING INFILTRATION OF ISLANDS  
OF MALIGNANT EPITHELIAL CELLS INTO THE 
UNDERLYING CONNECTIVE TISSUE 
 (H & E 100X) 
 
 
 
 
 
FIG 22B SHOWING MODERATE STAINING  
INTENSITY OF  ALPHA SMA POSITIVE 
MYOFIBROBLASTS (100X) 
 
 
FIG 22C SHOWING INFILTRATION OF ISLANDS OF 
MALIGNANT EPITHELIAL CELLS INTO THE UNDERLYING 
CONNECTIVE TISSUE (H & E 400X) 
 
 
 
 
FIG 22D SHOWING SPINDLE PATTERN OF 
DISTRIBUTION ALPHA SMA POSITIVE 
MYOFIBROBLASTS (100X) 
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POORLY DIFFERENTIATED SQUAMOUS CELL CARCINOMA 
 
 
FIG 23A SHOWING INFILTRATION OF ISLANDS  
OF MALIGNANT EPITHELIAL CELLS INTO  
THE UNDERLYING CONNECTIVE TISSUE  
(H & E 100X) 
 
 
 
 
 
FIG 23B SHOWING SEVERE STAINING 
 INTENSITY OF  ALPHA SMA POSITIVE 
 MYOFIBROBLASTS (100X) 
 
FIG 23C SHOWING INFILTRATION OF ISLANDS  
OF MALIGNANT EPITHELIAL CELLS INTO THE 
UNDERLYING CONNECTIVE TISSUE 
 (H & E 200X) 
 
 
 
FIG 23D SHOWING SEVERE STAINING 
 INTENSITY OF  ALPHA SMA POSITIVE 
MYOFIBROBLASTS (200X) 
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FIG 23E SHOWING INFILTRATION OF ISLANDS OF 
MALIGNANT EPITHELIAL CELLS INTO THE UNDERLYING 
CONNECTIVE TISSUE (H & E 400X) 
FIG 23F SHOWING NETWORK PATTERN OF 
DISTRIBUTION  OF  ALPHA SMA POSITIVE 
MYOFIBROBLASTS (400X) 
 
 
 
NORMAL ORAL MUCOSA 
 
 FIG 24A SHOWING EPITHELIUM AND  
CONNECTIVE TISSUE OF NORMAL ORAL  
MUCOSA (H&E 100X) 
 
 
 
FIG 24B SHOWING Α SMA POSITIVE ONLY  
IN THE BLOOD VESSELS (100X) 
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The role of stroma in the development and progression of malignant tumors is 
very important but the specific mechanisms for the activation and its effects on 
regulation of tumorigenesis remains unclear. 
43
One of the crucial events in the tumor 
stroma is acquisition of specialized fibroblasts called Myofibroblasts.
44
 As there is 
conversion of normal epithelium to precancerous and to squamous cell carcinoma, the 
stroma also changes from normal to primed to activated or tumor associated called as 
the stroma reaction.
45
 The altered epithelial cells of SCC would not be solely 
responsible for carcinogenesis, and different stromal factors participate in its 
development via communication with the epithelial elements.
46
 
MFs play a vital role in promoting ECM deposition, release of inflammatory 
mediators, and epithelial injury, all of which are considered as the key factors in 
perpetuating the cycle of injury and fibrosis.
47
 MFs are also the key cellular mediators 
in various fibrotic disorders. There is a significant role of MFs in tumor progression 
and invasion. 
46 
          Alpha-smooth muscle actin (alpha – SMA) is the actin isoform that 
predominated within vascular smooth-muscle cells and plays an important role in 
fibrogenesis. The expression of α SMA correlates with the activation of 
myofibroblasts.
47 
Smooth muscle actin has the potential to highlight cells with partial smooth 
muscle differentiation, such as pericytes, myoepithelial cells and myofibroblasts. Anti 
α-SMA is an excellent immunostain for tumors of smooth muscle differentiation.48 
 α-SMA positive stromal cells belong to the myofibroblast group and are 
found in pathological conditions but not in normal tissue.
49 
Therefore, the present study was aimed to compare the presence of stromal 
myofibroblasts in a wide range of oral potentially malignant and malignant lesions, 
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starting from healthy oral mucosa, leukoplakia, OSMF, Lichen Planus, Verrucous 
Carcinoma and different grades of OSCC. Quantitative and pattern wise analysis of 
stromal myofibroblasts using α SMA by IHC was done in all the study groups. 
Comparison of percentage of immunopositive myofibroblasts with other studies: 
ORAL LEUKOPLAKIA  
The stroma of most cases of leukoplakia (60%) was devoid of myofibroblasts, which 
is in accordance with the previous studies
16,21,41,50,56,59
 However, the remaining 40% of 
leukoplakia showed alpha SMA positive myofibroblasts, similar to the findings of 
other studies. 
28,31,38,41,52,58  
Costea et al stated that stromal cells, especially fibroblasts 
which regulate epithelial morphogenesis loses control and is progressively lost during 
neoplastic progression.
51
 Therefore, dysplasia represents an intermediate step, 
wherein the stroma is losing its control over epithelial morphogenesis.
31
 
ORAL SUBMUCOUS FIBROSIS  
Similar to leukoplakia, 60% of OSMF cases were devoid of myofibroblasts and 40% 
cases showed only 1% of immunopositive MFs .Some studie showed similar results 
of MF positivity 
24,28,63
 The presence of MFs in OSMF represents a failed wound 
healing process of the oral mucosa, caused by chronic irritation leading to scaring and 
fibrosis.
44
 The increase in MFs is directly related to the histologic stage of OSMF.  In 
a study according to Angadi et al
39
 an increase in myofibroblasts was observed from 
moderate to advanced stages of OSMF compared to early stage, which was in 
concordance with the earlier studies 
43,53  
But the results of the study by Singh et al 
have shown significance when compared with NOM.
21 
LICHEN PLANUS:  
In the present study, 40% of LP cases showed immunopositivity for alpha SMA 
which is in contrast to the previous study done by Parajuli et al.
25
 This could be 
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probably due to their diverse clinical types, of which erosive LP has an increased 
potential for malignancy. Till date, there is only one study evaluating myofibroblasts 
in OLP which has reported complete absence of Alpha SMA Positive Myofibroblasts. 
OLP being a common chronic inflammatory disease characterized by a disequilibrium 
in the expression patterns of various inflammation-related cytokines including 
transforming growth factor –β (TGF- β) and Interferon64 which are the master keys for 
myofibroblast activation.
65 
Ninomiya et al has stated that Myofibroblasts can be 
derived during the transdifferentiation of macrophages during the inflammatory 
process. This could account for the expression of myofibroblasts in our cases. 
VERRUCOUS CARCINOMA :  
In our study, all cases of VC (100%) showed immunopositivity for alpha 
SMA.Likewise, Chaudhary et al demonstrated a significant increase in 
myofibroblastic expression from premalignant lesions to VCs and SCC.
38
 On the 
contrary, Majeed et al observed complete lack of expression of α-smooth muscle actin 
myofibroblasts in oral VC cases as compared to complete positivity in OSCC which 
they attributed to the lack of inductive effect of genetically altered carcinomatous 
epithelium in VC. Similar results were reported 
36,32
. Yet another histological feature 
that can justify the absence of myofibroblasts in verrucous carcinoma is the intense 
inflammatory cell infiltrate that precedes the advancing front of the tumor. Kellerman 
et al stated that is a trend for occurrence of myofibroblasts to be inversely related to 
the inflammatory cell infiltration
50
.  
OSCC : 
The present investigation showed 100% of OSCC cases showing stromal 
immunopositivity with a gain of alpha SMA positive myofibroblasts with increasing 
grade of the tumour. This is in accordance with most studies
.(68,67,59,57,50,41,38) 
The 
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basement membrane which normally separates the epithelial and the stromal 
components is breached by the invading tumor cells, thereby bringing the epithelial 
components in close juxtaposition to the stromal components. This is accompanied by 
many stromal changes, of which the most important and one that facilitates tumor 
progression is the trans-differentiation of fibroblasts to myofibroblasts.
43 
This 
emphasizes the supportive role played by tumor stroma in order to develop potent 
therapeutic targets. 
            In a study by Jeyaraj et al
31
, among the three histological grades of OSCC, 
41% of the cases showed absence of myofibroblasts while 59% were positive for 
myofibroblasts. This heterogeneity in the presence of myofibroblasts has been 
previously reported
50,57,67
 and could be attributed to the varied secretion of 
transforming growth factor-β by the tumor cells66 which is essential for myofibroblast 
differentiation. The arrangement of myofibroblasts was confined to the stroma 
immediately adjacent to the tumor islands and tumor free stroma was devoid of 
myofibroblasts. The presence of myofibroblasts directly abutting the tumor cells 
suggest the possible role played by a tumor cell derived diffusible growth factor that 
promotes myofibroblast differentiation.
58
 
 This close proximity of tumor cells and myofibroblasts also supports two 
more hypothesis: 
 Myofibroblasts can possibly be derived from the epithelial mesenchymal 
transition of the tumor cells 
69,70
 
 Myofibroblasts play a key role in collective tumor invasion as they are 
capable of remodeling the ECM thereby providing the mechanical 
propulsive force that facilitates invasion.
70
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Contrasting the results of the present investigation, studies by Kellerman et al
41 
and 
Moghadam et al
15
 showed that there was no difference in the distribution of 
myofibroblasts between the three histological grades of SCC, stating that the 
transdifferentiation of myofibroblasts is a process that occurs independent of tumor 
differentiation. The results of De assiss et al
11
 showed statistically higher in high-
invasive OSCC than in low-invasive OSCC (p<0.05) describing that the pattern of 
invasion is an important histological parameter that reflects the invasive features of 
the tumor. 
16 
Comparison Of Staining Intensity Of MFs With Other Studies: 
In our study, majority of the cases i.e 40% of WDSCC, and 60% MDSCC and 
PDSCC showed 2% staining intensity which indicates MFs immunopositivity at 100X 
but not at 40X. The staining intensity of MFs when compared with that of OPMD 
group was not significant but it was statistically significant when compared with 
NOM group. These results were similar to that of previous studies done by Dodani    
et al
30
, Teena et al
37
, Angadi et al
39
. 
Comparison of Staining Index of MFs with other studies: 
Normal oral mucosa was devoid of myofibroblasts resulting in a Zero staining 
index in all the cases similar to that of previous studies.
27-32
 The alpha SMA staining 
was restricted only to the smooth muscles of the blood vessels. The staining index 
was found to be low in all cases of VC and 20% of WDSCC, moderate in 40% of 
WDSCC, 60% of MDSCC, 60% OF PDSCC and high in 40% of MDSCC and 
PDSCC. But Jayaraj et al
31
 has reported comparatively lesser values for OSCC with 
negative  in most cases (54.7%), low in 21.4% and moderate in 23.8% cases. All cases 
of VC had ZERO staining index, as seen in our study. The stroma of most of the cases 
(60%) of OL and OSMF had Zero Staining Index and only few cases (12.5%) of 
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OSMF showed low staining index for myofibroblast. Significant variation was noted 
in the results of Singh et al 
21
which showed 60% of cases with Moderate and 40% of 
cases with High Staining index. 
In a study by Rao et al
34
, all the cases of OSCC demonstrated intense staining 
and OSMF with dysplasia showed high staining indices, indicating (alpha)-SMA 
expression in the stroma of OSCC was greater than that in OSMF with dysplasia and 
that it was in accordance with the role of (alpha)-SMA positive myofibroblasts in 
invasive behaviour of OSCC. 
Comparison of Pattern of Distribution of Stromal Myofibroblast with supporting 
studies:  
In the present study, 20% of Oral leukoplakia, 40% of OSMF, 80% of OLP 
showed Focal pattern. Patterns of stromal myofibroblasts distribution in oral 
potentially malignant disorders were not mentioned in earlier studies. In the study by 
Vered et al 
59
, “spindle” pattern was observed in 77% cases of OSCC whereas in our 
study  it was found in 40% of VC, 80% WDSCC, 40% MDSCC and 60% PDSCC . 
The MFs were aligned in an orderly manner at the periphery of the tumor 
islands/nests and there were distinct borders between these cells and the malignant 
ones. Even among cases of carcinoma, however, the frequency of these cells was not 
uniform, ranging from cases with few stromal MF to cases in which MF constituted a 
major component of all the stroma.  
In our study 20% of WDSCC and 40% of MDSCC and PDSCC showed 
network pattern. 
In the study by Vered et al
60
, 23% cases of carcinoma exhibited a “network” 
pattern of SMF with large, usually vesicular nuclei with abundant cytoplasm that 
demonstrated cytoplasmic projections, which interconnected among neighbouring 
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SMF and formed a network around the carcinoma islands. The fine boundary between 
the stromal and epithelial compartments was often breached and a physical 
connection between the SMF and the carcinoma cells was apparent. Under these 
circumstances, the SMF acquired an epithelioid appearance, forming syncytial 
connections between them and the carcinoma cell.  
Vered et al.
59,60
 proposed that higher the number of MFs, more aggressive is 
the tumor with increased recurrence and poor survival rate. This can be attributed to 
the fact that the MFs are „factories‟ of a range of cytokines and growth factors, such 
as matrixmetalloproteases (MMPs), vascular endothelial growth factors (VEGFs), 
fibroblast growth factor (FGF). 
Through production of cytokines, chemokines, and proteolytic enzymes MFs 
modulate the tumor stroma by boosting tumor angiogenesis and by guiding tumor 
invasion, and metastasis thereby helping tumor progression. Increased frequency of 
MFs in the stroma has been associated with poor prognosis due to decreased survival 
rate and increased recurrence. Hence the carcinomas with higher expression of MF 
might be more aggressive and have poor prognosis, and hence are recommended for 
aggressive treatment and close follow-up. 
Another striking feature in our study is that alpha SMA positivity was 
observed in the epithelium of the study groups. OL and OLP showed nuclear 
positivity with mild to moderate intensity mostly distributed in the basal and parabasal 
layers of the epithelium whereas most of the OSMF cases showed mild cytoplasmic 
positivity. In OMD there is an increase in the expression of MF in the tumor stroma, 
which is strongly suggestive of a poor prognosis and high recurrence rate. Hence 
higher expression of α-SMA in tumor stroma can be effectively utilized for aggressive 
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treatment planning and for post treatment follow up. However the clinical significance 
of this epithelial positivity has not been cited in the literature so far. 
On evaluation of this series of lesions, the absence of myofibroblasts in the 
stroma of most of the cases of dysplasia, indicate myofibroblasts differentiation to be 
an event that occurs late in the carcinogenesis process and is not an ideal marker to 
relate its malignant transformation potential. With regard to the cases of OSMF the 
possible role of myofibroblast in the pathogenesis and in malignant transformation 
has been suggested. It also confirms the essential role of myofibroblasts in the stroma 
of SCC promoting tumor progression. 
Since lichen plans shows higher expression of MF in our study unlike previous 
studies. A larger sample size with all the clinical subtypes has to be included to 
substantiate our findings.  
In VC we have found higher expression of MF and there is only one study 
done earlier is in accordance with our findings. The higher expression of MF in our 
study could be due the inductive effect of genetically altered epithelium.  
Future attempts should be directed in identifying the exact stage of occurrence 
of myofibroblasts in the stroma in PMDs and malignancy. This is quite a challenging 
task, as dysplasia is not a sequential process as not all epithelial dysplasias progress to 
malignancy. The earliest event in carcinoma is most often missed in routine diagnosis 
making it difficult to identify these stromal cells at an early stage. However, further 
research involving larger sample size along with follow‑up studies will clearly 
elucidate our findings. 
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Despite the increasing number of studies illustrating the role of tumor 
microenvironment in cancer progression, a significant knowledge gap exists with 
respect to the identification, appearance and the exact role of MFs in tumor growth 
and progression especially in OSCCs. Therefore the present study was an attempt to 
reinforce the hypothesis that MFs are essentially a part of reactive tumor stroma and 
establish the quantitative and qualitative relationship of MFs at the invasive front with 
the biological behaviour of OSCC and also to ascertain its role in potentially 
malignant lesions like Leukoplakia, Oral Lichen Planus and Oral Submucous Fibrosis. 
The results of our study projected an increased number of alpha SMA positive 
myofibroblasts and change in the distribution pattern during the process of 
carcinogenesis indicating their role in tumor invasion and metastasis. It is presumed 
that the network pattern of MF arrangement is responsible for higher invasiveness and 
metastasis. Increased number of Alpha SMA positive MFs was seen with higher grade 
of OSCC. Focal and spindle pattern of distribution were observed in most of the 
OPMD except for few cases of Oral Lichen planus which has shown Network pattern 
of distribution as seen in OSCC. The staining index was Zero to Low in potentially 
malignant lesion while cases of OMD group showed Moderate to High staining index.  
From our study, we can conclude that myofibroblasts play a vital role for the invasive 
behaviour of OMD when compared to that of OPMD. 
However, further studies with DESMIN and VIMENTIN would help to 
establish the definitive role of MFs in tumor invasion and metastasis with greater 
specificity.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
Understanding the role of the stromal cells and extracellular matrix will enable 
us to identify more precise diagnostic modalities, prognostic markers and define 
therapeutic.targets.
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ANNEXURES 
 
  
  
IMMUNOEXPRESSION OF ALPHA SMA IN ORAL POTENTIALLY MALIGNANT DISORDERS (GROUP 1) 
S.No Category Age Gender Site Percentage Intensity Staining index Distribution pattern 
1 OL 70 Male Buccal mucosa 0% 0% Zero Absent 
2 OL 62 Female Buccal mucosa 1-25% 2% Low Spindle 
3 OL 37 Female Buccal mucosa 1-25% 2% Low Focal 
4 OL 39 Male Buccal mucosa 0% 0% Zero Absent 
5 OL 55 Male Buccal mucosa 0% 0% Zero Absent 
6 OMFS 45 Male Buccal mucosa 0% 0% Zero Absent 
7 OMFS 47 Male Buccal mucosa 0% 0% Zero Absent 
8 OMFS 53 Male Buccal mucosa 1-25% 2% Low Focal 
9 OMFS 64 Male Buccal mucosa 1-25% 1% Low Focal 
10 OMFS 67 Male Buccal mucosa 0% 0% Zero Absent 
11 OLP 40 Female Alveolus 25-50%% 2% Moderate Focal 
12 OLP 47 Male Buccal mucosa 25-50% 2% Moderate Network 
13 OLP 65 Female Lip 1-25% 1% Low Focal 
14 OLP 66 Male Lip 1-25% 1% Low Focal 
15 OLP 56 Female Buccal mucosa 1-25% 1% Low Focal 
  
  
                         IMMUNOEXPRESSION OF ALPHA SMA IN ORAL MALIGNANT DISORDERS (GROUP 2) 
S.No Category Age Gender Site Percentage Intensity Staining Index Distribution 
16 VC 55 Male Lip 1-25% 2% Low Spindle 
17 VC 58 Female Buccal mucosa 1-25% 2% Low Focal 
18 VC 56 Female Buccal mucosa 1-25% 2% Low Focal 
19 VC 58 Male Lip 1-25% 2% Low Focal 
20 VC 48 Male Buccal mucosa 1-25% 2% Low Spindle 
21 WDSCC 47 Male Buccal mucosa 25-50% 3% High Spindle 
22 WDSCC 54 Female Lip 25-50% 2% Moderate Spindle 
23 WDSCC 62 Male Buccal mucosa 50-100% 3% High Network 
24 WDSCC 45 Male Buccal mucosa 1-25% 1% Low Spindle 
25 WDSCC 31 Male Buccal mucosa 25-50% 2% Moderate Spindle 
  
S.No Category Age Gender Site Percentage Intensity Staining Index Distribution 
26 MDSCC 58 Female Alveolus 25-50% 2% Moderate Spindle 
27 MDSCC 54 Male Tongue 25-50% 2% Moderate Focal 
28 MDSCC 67 Female Lip 25-50% 3% High Network 
29 MDSCC 55 Female Alveolus 25-50% 2% Moderate Spindle 
30 MDSCC 65 Female Buccal mucosa 50-100% 3% High Network 
31 PDSCC 36 Male Buccal mucosa 50-100% 3% High Network 
32 PDSCC 48 Male Buccal mucosa 25-50% 2% Moderate Spindle 
33 PDSCC 48 Male Buccal mucosa 25-50% 2% Moderate Spindle 
34 PDSCC 67 Male Buccal mucosa 50-100% 3% High Network 
35 PDSCC 61 Female Buccal mucosa 50-100% 2% High Spindle 
  
                             IMMUNOEXPRESSION OF ALPHA SMA IN NORMAL ORAL MUCOSA GROUP (GROUP 3) 
 
 
 
S.No Category Age Gender Site 
Percentage 
 
Intensity Staining index Distribution Pattern 
36 NOM 32 Female Gingiva 0% 0% Zero Absent 
37 NOM 34 Female Gingiva 0% 0% Zero Absent 
38 NOM 36 Female Gingiva 0% 0% Zero Absent 
39 NOM 37 Male Gingiva 0% 0% Zero Absent 
40 NOM 31 Male Gingiva 0% 0% Zero Absent 
41 NOM 32 Female Gingiva 0% 0% Zero Absent 
42 NOM 33 Female Gingiva 0% 0% Zero Absent 
43 NOM 40 Male Gingiva 0% 0% Zero Absent 
44 NOM 42 Male Gingiva 0% 0% Zero Absent 
45 NOM 44 Female Gingiva 0% 0% Zero Absent 
46 NOM 41 Male Gingiva 0% 0% Zero Absent 
47 NOM 46 Male Gingiva 0% 0% Zero Absent 
48 NOM 47 Female Gingiva 0% 0% Zero Absent 
49 NOM 49 Male Gingiva 0% 0% Zero Absent 
50 NOM 48 Male Gingiva 0% 0% Zero Absent 
